Summary
Machine-generated summaryThis Polish tender covers successive deliveries of medicinal products used under Hospital Drug Programmes and chemotherapy over a period of 24 months, in accordance with the pricing form and the terms of the invitation to tender (SWZ). The products include oncology and immunomodulating medicines such as ocrelizumab, ozanimod, siponimod, nusinersen, efgartigimod alfa, ublituximab, ravulizumab, baricitinib, etanercept, upadacitinib, ixekizumab, bimekizumab, dupilumab, tezepelumab, obinutuzumab, venetoclax, ibrutinib, aflibercept, faricimab, romosozumab, mavacamten, anagrelide, bendamustine hydrochloride, bortezomib, carboplatin, cladribine, cisplatin, ropeginterferon alfa-2b, denosumab and doxorubicin hydrochloride. Quantities and detailed delivery schedules are set out in the pricing form.
Description
36 lots
- Lot 1
- 1. Ocrelizumabum 36 months
- Lot 2
- 2. Ozanimodum 36 months
- Lot 3
- 3. Siponimodum 36 months
- Lot 4
- 4. Nusinersenum 36 months
- Lot 5
- 5. Efgartigimod alfa 36 months
- Lot 6
- 6. Ublituximabum 36 months
- Lot 7
- 7. Ravulizumabum 36 months
- Lot 8
- 8. Baricitinibum 36 months
- How tenders are scored
- Price: 100 percent
- Small firms
- The buyer marks this procedure as suitable for small and medium-sized firms.
Show 28 more lots
- Lot 9
- 9. Etanerceptum 36 months
- Lot 10
- 10. Upadacitinibum 36 months
- Lot 11
- 11. Ixekizumabum 36 months
- Lot 12
- 12. Bimekizumabum 36 months
- Lot 13
- 13. Dupilumabum 36 months
- Lot 14
- 14. Tezepelumabum 36 months
- Lot 15
- 15. Obinutuzumabum 36 months
- Lot 16
- 16. Venetoclaxum 36 months
- Lot 17
- 17. Ibrutinibum 36 months
- Lot 18
- 18. Afliberceptum 36 months
- Lot 19
- 19. Farycymab 36 months
- Lot 20
- 20. Romosozumabum 36 months
- Lot 21
- 21. Mavacamtenum 36 months
- Lot 22
- 22. Anagrelidum 36 months
- Lot 23
- 23. Bendamustini hydrochloridum 36 months
- Lot 24
- 24. Bortezomibum 36 months
- Lot 25
- 25. Carboplatinum 36 months
- Lot 26
- 26. Cladribinum 36 months
- Lot 27
- 27. Cisplatinum 36 months
- Lot 28
- 28. Ropeginterferonum alfa-2b 36 months
- Lot 29
- 29. Denosumabum 36 months
- Lot 30
- 30. Doxorubicini hydrochloridum 36 months
- Lot 31
- 31. Gemcitabinum 36 months
- Lot 32
- 32. Pegfilgrastimum 36 months
- Lot 33
- 33. Topotecanum 36 months
- Lot 34
- 34. Vincristini sulfas 36 months
- Lot 35
- 35. Rasburicasum 36 months
- Lot 36
- 36. Darbepoetinum alfa 36 months
As the official notice states them.
Official source
Source: TED - Tenders Electronic Daily (Publications Office of the EU)
Always verify details on the official notice.
Report an error in this notice
Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 2 days ago
The buyer
Full buyer profile10 Wojskowy Szpital Kliniczny z Polikliniką Samodzielny Publiczny Zakład Opieki Zdrowotnej
- notices in the register
- 445
- awards
- 174
- awarded in total
- €184.1M
Who wins its contracts
Many suppliers- different companies won its awards
- 148
- of the awards went to the three most frequent winners
- 6%
- of its calls state an estimated value
- 0%
Based on 159 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.
Competition
- tenders per lot on average (open and restricted procedures)
- 1.6
- of those lots received a single tender
- 68%
- of the awards went to companies based in another country
- 3%
As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.
One dot per award, on the day it was signed, sized by its value. A ring is an award with no published value.
Awards most often to
4 open tenders right now
- Successive delivery of washing, disinfecting and laundry-boosting agents for hospital linen together with an automatic dosing system 1 day left
- Supply of chemical reagents, compounding substances and pharmacy utensils for 12 months 3 days left
- Repairs and installation of Tarkett type flooring in hospital buildings 7 days left
Market context
- open now in Medical equipment & pharmaceuticals
- 8,119
- median open notice
- €311,053
Who wins in this market
Many suppliersPoland · Medical equipment & pharmaceuticals
- different companies won awards here
- 13,424
- of the awards went to the three most frequent winners
- 4%
- buyers awarded contracts here
- 1,462
Based on 23,003 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.
Competition
- tenders per lot on average (open and restricted procedures)
- 1.8
- of those lots received a single tender
- 63%
- of the awards went to companies based in another country
- 2%
- of the tenders came from another country
- 2%
As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.
Similar tenders
Open now
Awarded before
Never miss a tender like this
983 new notices in Medical equipment & pharmaceuticals in Poland in the last 7 days. Get an email when new ones appear. Free.
Set up my alertOr follow just its CPV code, Antineoplastic and immunomodulating agents: an email when new tenders arrive under it, no account needed.